These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23150696)

  • 1. Hodgkin lymphoma: protecting the victims of our success.
    Cheson BD
    J Clin Oncol; 2012 Dec; 30(36):4456-7. PubMed ID: 23150696
    [No Abstract]   [Full Text] [Related]  

  • 2. Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?
    Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
    Nucl Med Commun; 2016 Jan; 37(1):23-9. PubMed ID: 26440567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Ann Nucl Med; 2015 Feb; 29(2):132-7. PubMed ID: 25348549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance.
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Eur J Haematol; 2015 Jul; 95(1):83-9. PubMed ID: 25537478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.
    Moog F; Bangerter M; Kotzerke J; Guhlmann A; Frickhofen N; Reske SN
    J Clin Oncol; 1998 Feb; 16(2):603-9. PubMed ID: 9469348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change of initial staging at early remission evaluation with FDG-PET/CT in Hodgkin lymphoma: a report of two cases.
    Molin D; Hagberg H; Suurküla M; Aström G
    Acta Oncol; 2010 May; 49(4):526-8. PubMed ID: 20397779
    [No Abstract]   [Full Text] [Related]  

  • 7. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma.
    El-Galaly TC; d'Amore F; Mylam KJ; de Nully Brown P; Bøgsted M; Bukh A; Specht L; Loft A; Iyer V; Hjorthaug K; Nielsen AL; Christiansen I; Madsen C; Johnsen HE; Hutchings M
    J Clin Oncol; 2012 Dec; 30(36):4508-14. PubMed ID: 23150698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse 18F-fluorodeoxyglucose accumulation in the bone marrow of a patient with haemophagocytic lymphohistiocytosis due to Hodgkin lymphoma.
    Harada S; Shinohara T; Naruse K; Machida H
    BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27793796
    [No Abstract]   [Full Text] [Related]  

  • 9. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma.
    Adams HJ; Nievelstein RA; Kwee TC
    Blood Rev; 2015 Nov; 29(6):417-25. PubMed ID: 26113144
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
    Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ
    Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of bone marrow involvement by FDG-PET for refractory Hodgkin lymphoma treated by unrelated allogeneic bone marrow transplantation].
    Toubai T; Ota S; Onodera M; Baba U; Fujisawa F; Miura Y; Toyoshima N; Tanaka J; Asaka M; Imamura M
    Rinsho Ketsueki; 2003 Jul; 44(7):446-50. PubMed ID: 12931562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone scanning and radiography in the evaluation of patients with malignant lymphoma.
    Jánoskuti L; Szilvási I; Papp G; Róna E; Benedek S; Fekete S
    Rofo; 1988 Oct; 149(4):427-8. PubMed ID: 2845515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone marrow disease revealed by leukocyte scintigraphy in a patient with relapsing fever of unknown origin].
    Mortensen JC; Lindberg JA
    Ugeskr Laeger; 1994 Jun; 156(23):3503-4. PubMed ID: 8066869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study.
    Pelosi E; Penna D; Douroukas A; Bellò M; Amati A; Arena V; Passera R; Bisi G
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):469-75. PubMed ID: 21150862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone lymphoma].
    Merino Menéndez S; Vega González ML; Blanco Cabellos JA
    Sangre (Barc); 1998 Dec; 43(6):521-5. PubMed ID: 10089813
    [No Abstract]   [Full Text] [Related]  

  • 17. CD30-positive primary bone marrow lymphoma mimicking Hodgkin lymphoma.
    Suzuki T; Kusumoto S; Masaki A; Ishida T; Inagaki H; Iida S; Mori F
    Int J Hematol; 2015 Feb; 101(2):109-11. PubMed ID: 25430086
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma.
    Agrawal K; Mittal BR; Bansal D; Varma N; Srinivasan R; Trehan A; Manohar K; Kashyap R; Bhattacharya A; Marwaha RK
    Ann Nucl Med; 2013 Feb; 27(2):146-51. PubMed ID: 23143537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG uptake in liposclerosing myxofibrous tumor causes upstaging of Hodgkin lymphoma.
    Kim J; Chen W; Resnik C; Dilsizian V; Chen Q; Kimball AS
    Clin Nucl Med; 2015 Apr; 40(4):325-7. PubMed ID: 25290293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin lymphoma-associated paraneoplastic cerebellar degeneration on FDG-PET/CT.
    Gheysens O; Deroose CM; Tousseyn T; Goffin K; Verhoef G; Dierickx D
    Br J Haematol; 2014 Feb; 164(4):468. PubMed ID: 24460525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.